NTRP vs. SHPW, JCSE, HEPA, GHSI, AZRX, ACST, SNSS, AMCR, HI, and BRC
Should you be buying Neurotrope stock or one of its competitors? The main competitors of Neurotrope include Shapeways (SHPW), JE Cleantech (JCSE), Hepion Pharmaceuticals (HEPA), Guardion Health Sciences (GHSI), AzurRx BioPharma (AZRX), Acasti Pharma (ACST), Sunesis Pharmaceuticals (SNSS), Amcor (AMCR), Hillenbrand (HI), and Brady (BRC).
Neurotrope (NASDAQ:NTRP) and Shapeways (NYSE:SHPW) are both small-cap consumer discretionary companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, community ranking, valuation, dividends and risk.
Neurotrope has a beta of 1.67, suggesting that its share price is 67% more volatile than the S&P 500. Comparatively, Shapeways has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.
Shapeways has a consensus price target of $3.00, indicating a potential upside of 194.12%. Given Shapeways' higher possible upside, analysts clearly believe Shapeways is more favorable than Neurotrope.
Neurotrope has higher earnings, but lower revenue than Shapeways. Neurotrope is trading at a lower price-to-earnings ratio than Shapeways, indicating that it is currently the more affordable of the two stocks.
3.8% of Neurotrope shares are held by institutional investors. Comparatively, 25.7% of Shapeways shares are held by institutional investors. 9.7% of Neurotrope shares are held by insiders. Comparatively, 28.2% of Shapeways shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Neurotrope received 172 more outperform votes than Shapeways when rated by MarketBeat users. Likewise, 63.38% of users gave Neurotrope an outperform vote while only 36.36% of users gave Shapeways an outperform vote.
In the previous week, Neurotrope and Neurotrope both had 1 articles in the media. Neurotrope's average media sentiment score of 0.00 equaled Shapeways'average media sentiment score.
Shapeways has a net margin of -127.43% compared to Neurotrope's net margin of -1,123.90%. Shapeways' return on equity of -69.04% beat Neurotrope's return on equity.
Summary
Shapeways beats Neurotrope on 10 of the 15 factors compared between the two stocks.
Get Neurotrope News Delivered to You Automatically
Sign up to receive the latest news and ratings for NTRP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NTRP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Neurotrope Competitors List
Related Companies and Tools
